Endometrial carcinoma with extra-abdominal metastasis: Improved prognosis following cytoreductive surgery

Annals of Surgical Oncology

Volumn 17, Issue 4, 2010, Pages 1111-1117

  Ueda, Yutaka ^a   Enomoto, Takayuki ^a   Miyatake, Takashi ^a   Egawa Takata, Tomomi ^a   Ugaki, Hiromi ^a   Yoshino, Kiyoshi ^b   Fujita, Masami ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL;

ADENOCARCINOMA, CLEAR CELL; AGED; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952095167     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0892-8     Document Type: Article

References (18)

1. DiSaia PJ, Creasman WT. Clinical gynecologic oncology, 6th ed. Mosby, St. Louis; 2002.
2. RE Bristow MJ Zerbe NB Rosenshein FC Grumbine FJ Montz 2000 Stage IVb endometrial carcinoma: The role of cytoreductive surgery and determinants of survival Gynecol Oncol 78 85 91 10.1006/gyno.2000.5843 1:STN:280: DC%2BD3cvht1eksA%3D%3D 10926785 (Pubitemid 30650336)
3. AH Wolfson SE Sightler AM Markoe JG Schwade HE Averette P Ganjei, et al. 1992 The prognostic significance of surgical staging for carcinoma of the endometrium Gynecol Oncol 45 142 146 10.1016/0090-8258(92)90276-O 1:STN:280:DyaK383nsFCgtg%3D%3D 1592280
4. BD Marino TW Burke C Tornos L Chuang MF Mitchell G Tortolero-Luna, et al. 1995 Staging laparotomy for endometrial carcinoma: Assessment of peritoneal spread Gynecol Oncol 56 34 38 10.1006/gyno.1995.1006 1:STN:280: DyaK2M7itF2luw%3D%3D 7821845
5. JR Vardi GH Tadros MT Anselmo SD Rafla 1992 The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging Obstet Gynecol 80 204 208 1:STN:280:DyaK38zkt1ertg%3D%3D 1635733
6. WJ Hoskins WP McGuire MF Brady HD Homesley WT Creasman M Berman, et al. 1994 The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am J Obstet Gynecol 170 974 979 1:STN:280:DyaK2c3hvFGntQ%3D%3D 8166218 (Pubitemid 24157907)
7. RE Bristow RS Tomacruz DK Armstrong EL Trimble FJ Montz 2002 Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis J Clin Oncol 20 1248 1259 10.1200/JCO.20.5. 1248 11870167 (Pubitemid 34177431)
8. A Ayhan C Taskiran C Celik K Yuce T Kucukali 2002 The influence of cytoreductive surgery on survival and morbidity in Stage IVb endometrial cancer Int J Gynecol Cancer 12 448 453 10.1046/j.1525-1438.2002.t01-1-01133.x 1:STN:280:DC%2BD38nhtV2msw%3D%3D 12366661
9. DS Chi M Welshinger ES Venkatraman RR Barakat 1997 The role of surgical cytoreduction in Stage IV endometrial carcinoma Gynecol Oncol 67 56 60 10.1006/gyno.1997.4838 1:STN:280:DyaK1c%2FgsFWlug%3D%3D 9345357 (Pubitemid 27433329)
10. FH van Wijk ME van der Burg CW Burger I Vergote HC van Doorn 2009 Management of surgical stage III and IV endometrioid endometrial carcinoma: An overview Int J Gynecol Cancer 19 431 446 19407572
11. PJ Hoskins KD Swenerton JA Pike F Wong P Lim C Acquino-Parsons, et al. 2001 Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study J Clin Oncol 19 4048 4053 1:CAS:528:DC%2BD3MXotVakt7w%3D 11600606 (Pubitemid 32976691)
12. Papadimitriou CA, Bafaloukos D, Bozas G, Kalofonos H, Kosmidis P, Aravantinos G, et al. Hellenic Co-operative Oncology Group. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Co-operative Oncology Group (HeCOG) study. Gynecol Oncol. 2008;110:87-92. (Pubitemid 351892585)
13. A Lissoni A Gabriele G Gorga S Tumolo F Landoni C Mangioni, et al. 1997 Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma Ann Oncol 8 969 972 10.1023/A:1008221310453 1:STN:280: DyaK1c%2FmtlOlsw%3D%3D 9402169 (Pubitemid 27475727)
14. BA Goff A Goodman HG Muntz AF Fuller Jr N Nikrui LW Rice 1994 Surgical stage IV endometrial carcinoma: A study of 47 cases Gynecol Oncol 52 237 240 10.1006/gyno.1994.1038 1:STN:280:DyaK2c7kvVartQ%3D%3D 8314145 (Pubitemid 24064377)
15. RE Bristow LR Duska FJ Montz 2001 The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma Gynecol Oncol 81 92 99 10.1006/gyno.2000.6110 1:STN:280:DC%2BD3M7ptVWjsA%3D%3D 11277657 (Pubitemid 32368085)
16. S Memarzadeh CH Holschneider RE Bristow NL Jones YS Fu BY Karlan, et al. 2002 FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival Int J Gynecol Cancer 12 454 458 10.1046/j.1525-1438.2002.01149.x 1:STN:280:DC%2BD38nhtV2msA%3D%3D 12366662
17. MB Thomas A Mariani WA Cliby GL Keeney KC Podratz SC Dowdy 2007 Role of cytoreduction in stage III and IV uterine papillary serous carcinoma Gynecol Oncol 107 190 193 10.1016/j.ygyno.2007.05.039 17825394 (Pubitemid 47575711)
18. NC Lambrou O Gómez-Marín R Mirhashemi H Beach E Salom Z Almeida-Parra, et al. 2004 Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: A study of morbidity and survival Gynecol Oncol 93 653 658 10.1016/j.ygyno.2004.03.015 15196860 (Pubitemid 38766051)